THROMBOPROPHYLAXIS

Clinical trials for THROMBOPROPHYLAXIS explained in plain language.

Never miss a new study

Get alerted when new THROMBOPROPHYLAXIS trials appear

Sign up with your email to follow new studies for THROMBOPROPHYLAXIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2 Completed 1

Pill vs. needle: can a simple tablet prevent dangerous clots after leg injuries?

Disease control Recruiting now

This study compares two blood thinners—rivaroxaban (a pill) and low-molecular-weight heparin (a daily injection)—in people with leg injuries that require a cast or brace for at least two weeks. The goal is to see if the pill is as good as or better than the injection at preventin…

Matched conditions: THROMBOPROPHYLAXIS

Phase: PHASE3 • Sponsor: University Hospital, Angers • Aim: Disease control

Last updated May 17, 2026 05:29 UTC

THROMBOPROPHYLAXIS

Get alerted when new THROMBOPROPHYLAXIS trials appear

Pill vs. needle: can a simple tablet prevent dangerous clots after leg injuries?